Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 31.900000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 34.100000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 33.940000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 27.250000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 22.040000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 19.840000
Brief: Cel-Sci Says Financial Statements Within Quarterly Reports For Quarter Ended Dec 31, 2019, March 31, 2020, & June 30, 2020 Should Not Be Relied Upon
Brief: CEL-SCI Announces Update On Phase 3 Cancer Trial Results
Brief: CEL-SCI Says Awarded European Patent For LEAPS Vaccine In Treatment Of Rheumatoid Arthritis
Brief: Cel-Sci Corporation Reports Qtrly Loss Per Share Of $0.27
Brief: CEL-SCI Posts Qtrly Loss Per Share $0.68
Brief: Cel-Sci Announces Early Results With Covid 19 Leaps Vaccine/Treatment
Brief: CEL-SCI Corporation Receives $10 Million Through Warrant Exercises